Kreft, B., Fischer, A., Kruger, S., Sack, K., Kirchner, H., and Rink, L. The impaired immune response to diphtheria vaccination in elderly chronic hemodialysis patients is related to zinc deficiency Biogerontology. 2000, 1 (1): 6166. Kumar, V., Sercarz, E., Zhang, J., and Cohen, I. Tcell vaccination: from basics to the clinic Trends Immunol. 2001, 22 (10): 539540. Kyaw, M. H., Bramley, J. C., Chalmers, J., Jones, I. G., and Campbell, H. Pneumococcal vaccination: opinion of general practitioners and hospital doctors in Scotland, 19992000 Commun.Dis.Public Health. 2001, 4 (1): 4248. Larzelere, R. E. We need the full picture on both smacking and vaccinations Arch.Dis.Child. 2001, 84 (5): 452. Law, B. J. Chickenpox vaccination, not chickenpox, should be routine for Canadian children CMAJ. 5152001, 164 (10): 14541455. LeBaron, C. W., Massoudi, M., Stevenson, J., and Lyons, B. Vaccination coverage and physician distribution in the united states, 1997 Pediatrics. 2001, 107 (3): E31. Leggat, P. A. Book Review: The Traveller's Pocket Medical Guide and International Certificate of Vaccination,3rd edition. J Travel Med 2001; 8(6): 336. Lehmann, D., Kakazo, M., Saleu, G., Taime, J., Javati, A., Namuigi, P., Alpers, M. P., Wegmuller, B., Zellmeyer, M., Furer, E., Que, J. U., and Herzog, C. Safety and Immunogenicity of Two Haemophilus Influenzae Type b PolysaccharideTetanus Toxoid Conjugate Vaccines (PRPT) Given With Diphtheria TetanusPertussis Vaccine to Young Papua New Guinean Children P N.G.Med.J 2001, 44 (12): 616 Lehrke, P., Nuebling, M., Hofmann, F., and Stoessel, U. Attitudes of homoeopathic physicians towards vaccination Vaccine. 9142001, 19 (32): 48594864. LevyBruhl, D. and Guerin, N. The use of smallpox virus as a biological weapon: the vaccination situation in France Euro.Surveill. 2001, 6 (11): 171178. Lewis, P. R., Reimer, R. F., and Dixon, A. J. Evaluating the efficacy of vaccine storage in the general practice setting Aust.N.Z.J.Public Health. 2001, 25 (6): 547550. Liddle, B. J. and Jennings, R. Influenza vaccination in old age Age Ageing. 2001, 30 (5): 385389. Linde, A. [Sweden behind when it comes to influenza vaccination. Better vaccination programs in many western countries] Lakartidningen. 1172001, 98 (3): 154155. Lopez, J. A., Weilenman, C., Audran, R., Roggero, M. A., Bonelo, A., Tiercy, J. M., Spertini, F., and Corradin, G. A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies Eur.J.Immunol. 2001, 31 (7): 19891998. Luman, E. T., Stokley, S., Daniels, D., and Klevens, R. M. Vaccination visits in early childhood(3)(3). Just one more visit to be fully vaccinated Am.J.Prev.Med. 2001, 20 (4 Suppl): 3240. MacLennan J, Obaro S, Deeks J, Lake D, Elie C, Carlone G, Moxon ER, Greenwood B. Immunologic Memory 5 Years after Meningococcal A/C Conjugate Vaccination in Infancy. J Infect Dis 2001 Jan;183(1):97104 Mahony, C. Vaccination. Nurse anxiety after GMC charges doctor over singledose MMR jabs. Nurs Times. 2001 Aug 1622;97(33):9. Mak, D. B., Plant, A. J., and Louise, Rushworth R. Where the data are deficient: a field evaluation of the effectiveness of pneumococcal vaccination in remote Australia Aust.J.Rural.Health. 2001, 9 (1): 3846. Mandl S, Hix L, Andino R. Preexisting immunity to poliovirus does not impair the efficacy of recombinant poliovirus vaccine vectors. J Virol 2001 Jan;75(2):6227 Manning, A. Referral of Dr. Peter Mansfield to the GMC. Should decision on vaccination be best for you or us? BMJ. 1212001, 323 (7324): 1304. Maral, I., Baykan, Z., Aksakal, F. N., Kayikcioglu, F., and Bumin, M. A. Tetanus immunization in pregnant women: evaluation of maternal tetanus vaccination status and factors affecting rate of vaccination coverage Public Health. 2001, 115 (5): 359364. Marianneau, P., Ge<strong>org</strong>esCourbot, M., and Deubel, V. Rarity of adverse effects after 17D yellowfever vaccination Lancet. 7142001, 358 (9276): 8485. Marth, E. and Kleinhappl, B. Albumin is a necessary stabilizer of TBEvaccine to avoid fever in children after vaccination Vaccine. 11122001, 20 (34): 532537. Martin, M., Tsai, T. F., Cropp, B., Chang, G. J., Holmes, D. A., Tseng, J., Shieh, W., Zaki, S. R., Al Sanouri, I., Cutrona, A. F., Ray, G., Weld, L. H., and Cetron, M. S. Fever and multisystem <strong>org</strong>an failure associated with 17D204 yellow fever vaccination: a report of four cases Lancet. 7142001, 358 (9276): 98104. Martin, M., Weld, L. H., Tsai, T. F., Mootrey, G. T., Chen, R. T., Niu, M., and Cetron, M. S. Advanced Age a Risk Factor for Illness Temporally Associated with Yellow Fever Vaccination. Emerg Infect Dis 2001; 7(6): 945951. Martin, S., Sadler, F., Borrow, R., Dawson, M., Fox, A., and Cartwright, K. IgG antibody subclass responses determined by immunoblot in infants' sera following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine Vaccine. 8142001, 19 (31): 44044408. Marufu, T. and Siziya, S. Impact of multiple dose measles vaccination on measles transmission patterns in Gweru, Zimbabwe J.Trop.Pediatr. 2001, 47 (6): 335338. Mas, Lago P., Caceres, V. M., Galindo, M. A., Gary, H. E., Jr., Valcarcel, M., Barrios, J., Sarmiento, L., Avalos, I., Bravo, J. A., Palomera, R., Bello, M., Sutter, R. W., Pallansch, M. A., and de Quadros, C. A. Persistence of vaccinederived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication Int.J.Epidemiol. 2001, 30 (5): 10291034. Mazzone, P. J., Mossad, S. B., Mawhorter, S. D., Mehta, A. C., Schilz, R. J., and Maurer, J. R. The humoral immune response to influenza vaccination in lung transplant patients Eur.Respir.J. 2001, 18 (6): 971976. McCarthy, M. Closing vaccination's "window of vulnerability" Lancet. 3312001, 357 (9261): 1022. McCormick, A., Dinakaran, S., Bhola, R., and Rennie, I. G. Recurrent sixth nerve palsy following measles mumps rubella vaccination Eye. 2001, 15 (Pt 3): 356357. McDade, T. W., Beck, M. A., Kuzawa, C., and Adair, L. S. Prenatal undernutrition, postnatal environments, and antibody response to vaccination in adolescence Am.J.Clin.Nutr. 2001, 74 (4): 543548. McDaid, D. and Maynard, A. Translating evidence into practice. The case of influenza vaccination Eur.J.Public Health. 2001, 11 (4): 453455. Michiels, B., Coenen, S., Avonts, D., Van Royen, P., and Denekens, J. Who benefits from an influenza vaccination of GPs? Vaccine. 10122001, 20 (12): 1 2. Mihalopoulos, N. L., Khan, A., and Wiese, J. Influenza: recommendations for vaccination and treatment J.La State Med.Soc. 2001, 153 (12): 596602. Miller, P. L., Frawley, S. J., and Sayward, F. G. Exploring the utility of demographic data and vaccination history data in the deduplication of immunization registry patient records J.Biomed.Inform. 2001, 34 (1): 3750. Miller, P. L., Frawley, S. J., and Sayward, F. G. Exploring the utility of demographic data and vaccination history data in the deduplication of immunization registry patient records J.Biomed.Inform. 2001, 34 (1): 3750. MMWR. Acute flaccid paralysis associated with circulating vaccinederived poliovirusPhilippines, 2001. MMWR Morb Mortal Wkly Rep. 2001 Oct 12;50(40):8745. Mollenkopf, H., Dietrich, G., and Kaufmann, S. H. Intracellular bacteria as targets and carriers for vaccination Biol.Chem. 2001, 382 (4): 521532. Mooi, F. R., van Loo, I. H., and King, A. J. Adaptation of Bordetella pertussis to Vaccination: A Cause for Its Reemergence? Emerg.Infect.Dis. 2001, 7 (3 Suppl): 526528. Moreno, S., Blazquez, R., Novoa, A., Carpena, I., Menasalvas, A., Ramirez, C., and Guerrero, C. The Effect of BCG Vaccination on Tuberculin Reactivity and the Booster Effect Among Hospital Employees Arch.Intern.Med. 7232001, 161 (14): 17601765. Moreton, J. MMR vaccination: the case for evidencebased practice Br.J.Community Nurs. 2001, 6 (4): 199200. Mori, O. [The first vaccination by cowpox in Inaba and Hoki] (Jpn) Nippon Ishigaku.Zasshi. 1991, 37 (4): 513533. Moriabadi, N. F., Niewiesk, S., Kruse, N., Jung, S., Weissbrich, B., ter, Meulen, V, Toyka, K. V., and Rieckmann, P. Influenza vaccination in MS: absence of Tcell response against white matter proteins Neurology. 4102001, 56 (7): 938943. Morimoto, N. The relationship between poliovirus multiplication, the sIgA antibody response and the serum neutralizing antibody titers after trivalent oral polio vaccination Kansenshogaku Zasshi. 2001, 75 (12): 10301039.
Mortimer, E. A. Jr, Ball, R., Ball, L. K., Wise, R. P., Braun, M. M., Beeler, J. A., and Salive, M. E. MrozekBudzyn, D. [Performance of vaccinations against poliomyelitis and measles in Malopolska province versus the plan for eradication and elimination of these diseases.] Przegl.Epidemiol. 2001, 55 (3): 355363. MrozekBudzyn, D. [The reasons of low performance and delaying in the compulsory vaccinations of children. The methods of research.] Przegl.Epidemiol. 2001, 55 (3): 343353. Muennig, P. A. and Khan, K. CostEffectiveness of Vaccination versus Treatment of Influenza in Healthy Adolescents and Adults Clin.Infect.Dis. 1212001, 33 (11): 18791885. Mulholland, K. and Barreto, M. L. Routine vaccination and child survival in GuineaBissau. Lessons can be learnt from this study BMJ. 2102001, 322 (7282): 360. Mysliwski, A., Trzonkowski, P., Szmit, E., Dobyszuk, A., Mysliwska, J., and Foerster, J. Antiinfluenza vaccination changes expression of CD45 isoforms on peripheral blood NK cells of the elderly Adv.Exp.Med.Biol. 2001, 495:3114. (): 311314. Nakase, H., Okazaki, K., Tabata, Y., Uchida, K., Uose, S., Ohana, M., Nishi, T., Watanabe, T., Matsuura, M., Hisatsune, H., Matsumura, K., Itoh, T., Kawanami, C., and Chiba, T. Rectal immunization with antigencontaining microspheres induces stronger Th2 responses than oral immunization: a new method for vaccination Vaccine. 11122001, 20 (34): 377384. Nettleman, M. D., White, T., Lavoie, S., and Chafin, C. Nichol, K. L. CostBenefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza Arch.Intern.Med. 3122001, 161 (5): 749759. Niu, M. T., Erwin, D. E., and Braun, M. M. Data mining in the US Vaccine Adverse Event Reporting System (): early detection of intussusception and other events after rotavirus vaccination Vaccine. 9142001, 19 (32): 46274634. Noped, J. C. and Schomberg, R. Implementing an inpatient pharmacybased pneumococcal vaccination program Am.J.Health Syst.Pharm. 1012001, 58 (19): 18521855. Ogra, P. L., Faden, H., and Welliver, R. C. Vaccination strategies for mucosal immune responses Clin.Microbiol.Rev. 2001, 14 (2): 430445. Ogura, M. and Ichimura, H. [Measles epidemic and investigation of the vaccination history in Chiba Prefecture in 2000. A report from Chiba epidemiological surveillance of tuberculosis and infectious diseases] Kansenshogaku Zasshi. 2001, 75 (8): 686691. Olson, A. D., Shope, T. C., and Flynn, J. T. Pretransplant varicella vaccination is costeffective in pediatric renal transplantation Pediatr.Transplant. 2001, 5 (1): 4450. Opstelten, W., Hak, E., Verheij, T. J., and van Essen, G. A. Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncompliance Am.J.Med. 10152001, 111 (6): 474479. Orellana, C. Mexican vaccine against typhoid fever in phase I trial Lancet Infect.Dis. 2001, 1 (5): 292. Orient, J. M. Public health risks of not vaccinating children JAMA. 3282001, 285 (12): 1573. Osterholm, M. T. How to vaccinate 30,000 people in three days: realities of outbreak management Public Health Rep. 2001, 116 Suppl 2:748. (): 7478. Parkkali, T., Vakevainen, M., Kayhty, H., Ruutu, T., and Ruutu, P. Opsonophagocytic activity against Streptococcus pneumoniae type 19F in allogeneic BMT recipients before and after vaccination with pneumococcal polysaccharide vaccine Bone Marrow Transplant. 2001, 27 (2): 207211. Paterson, R. Human trials start for new tuberculosis vaccine Lancet Infect.Dis. 2001, 1 (5): 291. Patja A, MakinenKiljunen S, Davidkin I, Paunio M, Peltola H. Allergic Reactions to MeaslesMumpsRubella Vaccination. Pediatrics 2001 Feb;107(2):E27 Pattison, H. and Pareek, M. Health professionals' attitudes to MMR vaccine. Advice in primary care affects parents' decision to take up MMR vaccination BMJ. 552001, 322 (7294): 1121. Pattison, S. Ethical debate: Vaccination against mumps, measles, and rubella: is there a case for deepening the debate? How safe is MMR vaccine? BMJ. 10 132001, 323 (7317): 840. Pertussis in Germany: regional differences in management and vaccination status of hospitalized cases Epidemiol.Infect. 2001, 127 (1): 6371. Pesanti, E. L. Immunologic defects and vaccination in patients with chronic renal failure Infect.Dis.Clin.North Am. 2001, 15 (3): 813832. Peters, P. H., Jr., Gravenstein, S., Norwood, P., De, Bock, V, Van Couter, A., Gibbens, M., von Planta, T. A., and Ward, P. Longterm use of oseltamivir for the prophylaxis of influenza in a vaccinated frail older population J.Am.Geriatr.Soc. 2001, 49 (8): 10251031. Petrovic M, Roberts R, Ramsay M. Second dose of measles, mumps, and rubella vaccine: questionnaire survey of health professionals. BMJ 2001 Jan 13;322(7278):825 Pichichero, M. E., Anderson, E. L., Rennels, M. B., Edwards, K. M., and England, J. A. Fifth vaccination with dipthteria, tetanus and acellular pertussis is beneficial in four to sixyearolds Pediatr.Infect.Dis.J. 2001, 20 (4): 427433. Plotkin, S. A. Vaccination against cytomegalovirus Arch.Virol.Suppl. 2001, 17): 121134. Poehling, K. A., Speroff, T., Dittus, R. S., Griffin, M. R., Hickson, G. B., and Edwards, K. M. Predictors of influenza virus vaccination status in hospitalized children. Pediatrics 2001; 108(6): 99. Pokorn, M., Kopac, S., Neubauer, D., and Cizman, M. Economic evaluation of Haemophilus influenzae type b vaccination in Slovenia Vaccine. 5142001, 19 (2526): 36003605. Pollard, A. J. and Scheifele, D. Meningococcal disease and vaccination in North America J.Paediatr.Child Health. 2001, 37 (5): S20S27. Pollard, A. J. and Scheifele, D. Meningococcal disease and vaccination in North America. J Paediatr Child Health 2001; 37(5): 2027. Ponnuraj EM, John TJ, Levin MJ, Simoes EA. Sabin attenuated LSc/2ab strain of poliovirus spreads to the spinal cord from a peripheral nerve in bonnet monkeys (Macaca radiata). J Gen Virol 2001 Jun;82(Pt 6):1329. Postma, M. J., Heijnen, M. L., and Jager, J. C. Costeffectiveness analysis of pneumococcal vaccination for elderly individuals in The Netherlands Pharmacoeconomics. 2001, 19 (2): 215222. Pronsati, M. P. Facts Support Immunization Adv.Nurse Pract. 2001, 9 (2): 11 Pyhala, R., Haanpaa, M., Kleemola, M., Tervahauta, R., Visakorpi, R., and Kinnunen, L. Acceptable protective efficacy of influenza vaccination in young military conscripts under circumstances of incomplete antigenic and genetic match Vaccine. 4302001, 19 (2324): 32533260. Pyhala, R., Ikonen, N., Santanen, R., Haanpaa, M., Visakorpi, R., Jappinen, P., and Valle, M. Vaccinationinduced HI antibody response to intraepidemic influenza A(H3N2) virus variants of the 19961997 epidemic season J.Med.Virol. 2001, 65 (3): 584589. Quail, P. Flu vaccination in Alberta longterm care facilities CMAJ. 11132001, 165 (10): 1299. Raaska, K., Raitasuo, V., and Neuvonen, P. J. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia Eur.J.Clin.Pharmacol. 2001, 57 (10): 705708. Rahman, M., Sekimoto, M., Takamatsu, I., Hira, K., Shimbo, T., Toyoshima, K., and Fukui, T. Economic evaluation of universal BCG vaccination of Japanese infants Int.J.Epidemiol. 2001, 30 (2): 380385. Ramsay, M., Slack, M., and Kaczmarski, E. Surveillance of Haemophilus influenzae infection. Surveillance data for assessing impact of vaccination are valid BMJ. 3102001, 322 (7286): 613614. Reeder, J. C. Towards a Malaria Vaccine for Papua New Guinea P N.G.Med.J 2001, 44 (12): 1723 Reichert, T. A., Sugaya, N., Fedson, D. S., Glezen, W. P., Simonsen, L., and Tashiro, M. The Japanese experience with vaccinating schoolchildren against influenza N.Engl.J.Med. 3222001, 344 (12): 889896. Riddell, M. A., Leydon, J. A., Ugoni, A., and Kelly, H. A. A serosurvey evaluation of the schoolbased measles 'catchup' immunisation campaign in Victorian schoolaged children Aust.N.Z.J.Public Health. 2001, 25 (6): 529533. Rodewald, L. E. and Santoli, J. M. The challenge of vaccinating vulnerable children J.Pediatr. 2001, 139 (5): 613615. RoosVan Eijndhoven, D. G., Cools, H. J., Westendorp, R. G., CateHoek, A. J., Knook, D. L., and Remarque, E. J. Randomized controlled trial of seroresponses to double dose and booster influenza vaccination in frail elderly subjects J.Med.Virol. 2001, 63 (4): 293298.
- Page 1 and 2: BIBLIOGRAFIA SUI DANNI DA VACCINI A
- Page 3 and 4: Alter HJ, Scanlon RT, Schechter GP.
- Page 5 and 6: Cherry, JD, et al. A Clinical and S
- Page 7 and 8: Kazarian EL, Gager WE. Optic neurit
- Page 9 and 10: Coplan J. Seizures following immuni
- Page 11 and 12: Ipp MM, Gold R, Greenberg S, Goldba
- Page 13 and 14: Int J Ped Oto, Feb 1998, 43(1):73
- Page 15 and 16: Mashikian MV, Stollerman GH. Vaccin
- Page 17 and 18: Wu T, Wang SL, Xiang YZ. Study on t
- Page 19 and 20: Prevots DR, Ciofi degli Atti ML, Sa
- Page 21 and 22: Del Giudice G, Pizza M, Rappuoli R.
- Page 23 and 24: Huber S, Kappos L, Fuhr P, Wetzel S
- Page 25 and 26: Ngui SL, Hallet R, Teo CG. Natural
- Page 27 and 28: Thomson J, Hilditch A, Pirkis J, Du
- Page 29 and 30: Belloni C, Pistorio A, Tinelli C, K
- Page 31 and 32: DanielRibeiro CT. Is there a role
- Page 33 and 34: Gallup, R. The MMR question [letter
- Page 35 and 36: Hull BP, McIntyre PB. A reevaluat
- Page 37 and 38: Lieu TA, Ray GT, Black SB, Butler J
- Page 39 and 40: Mulholland K. Evaluation of vaccine
- Page 41 and 42: Rudolph, K. M., Parkinson, A. J., R
- Page 43 and 44: Taylor JA, Newman RD. Parental atti
- Page 45 and 46: Bonaccorsi G, Papini D, Bonanni P,
- Page 47: Hanna, J. N., Young, D. M., Brookes
- Page 51 and 52: Taranger, J., Trollfors, B., Bergfo
- Page 53 and 54: Christensen, L. S., Scholler, S., S
- Page 55 and 56: Khanal, P. Nepal's Childhood Mortal
- Page 57 and 58: Poland GA, Jacobson RM, Vierkant RA
- Page 59 and 60: Vyse, A. J., Gay, N. J., White, J.
- Page 61 and 62: Brodkin, H. Economic Analysis of In
- Page 63 and 64: Freed, G. L., Davis, M. M., and Cla
- Page 65 and 66: Karlsen, T. H.; Sommerfelt, H.; Klo
- Page 67 and 68: NascimentoCarvalho, C. M.; Moreno
- Page 69 and 70: Skegg, D. C. Autism and MeaslesMu
- Page 71 and 72: Wharton, M., Strikas, R. A., Harpaz
- Page 73 and 74: Boyce, T. G.; Weaver, A. L.; St Sau
- Page 75 and 76: D'Heilly, S. J.; Nichol, K. L. Work
- Page 77 and 78: Guy, B.; Chanthavanich, P.; Gimenez
- Page 79 and 80: Koca, R.; Altinyazar, H. C.; Numano
- Page 81 and 82: Modlin, J. F. Poliomyelitis in the
- Page 83 and 84: Roost, H. P.; Gassner, M.; Grize, L
- Page 85 and 86: Vazquez, M.; LaRussa, P. S.; Gersho
- Page 87 and 88: Beaujean, D. J.; Verweij, M. F.; va
- Page 89 and 90: Desjeux, G.; GaloisyGuibal, L.; C
- Page 91 and 92: Gust, D.; Brown, C.; Sheedy, K.; Hi
- Page 93 and 94: Koch, D.; Thompson, L.; Swart, B. L
- Page 95 and 96: Newport, M. J.; Goetghebuer, T.; Ma
- Page 97 and 98: Satcher, D. Adult Immunization Disp
- Page 99 and 100:
Timmermans, D. R.; Henneman, L.; Hi
- Page 101 and 102:
Aaby, P.; Jensen, H.; Walraven, G.
- Page 103 and 104:
Carrat, F.; Lavenu, A.; Cauchemez,
- Page 105 and 106:
Emanuel, E. J.; Wertheimer, A. Publ
- Page 107 and 108:
Halperin, S. A.; Sweet, L.; Baxenda
- Page 109 and 110:
Klote, M. M.; Engler, R. J.; Martin
- Page 111 and 112:
Mitka, M. Age Range Widens for Pert
- Page 113 and 114:
Pool, V.; Iskander, J. Safety of In
- Page 115 and 116:
Skowronski, D. M.; Woolcott, J. C.;
- Page 117 and 118:
Vu, D. M.; Kelly, D.; Heath, P. T.;
- Page 119 and 120:
Approved: New Requirement Allowing
- Page 121 and 122:
Caldwell, S. J.; Hayney, M. S. Prop
- Page 123 and 124:
Dempsey, A. F. Vaccination Against
- Page 125 and 126:
Galvani, A. P.; Reluga, T. C.; Chap
- Page 127 and 128:
Influenza Vaccination Coverage Amon
- Page 129 and 130:
Lawrence, S. J.; Lottenbach, K. R.;
- Page 131 and 132:
Monath, T. P. Yellow Fever As an En
- Page 133 and 134:
Patrick, D. Prevention Strategies:
- Page 135 and 136:
Scheiblhofer, S.; Weiss, R.; Thalha
- Page 137 and 138:
Takada, T.; Yamashita, T.; Sato, M.
- Page 139 and 140:
Winston, C. A.; Mims, A. D.; Leathe
- Page 141 and 142:
Bechtol, Z. Launching a Community
- Page 143 and 144:
Chumakov, K.; Ehrenfeld, E. Vaccine
- Page 145 and 146:
Dylag, A. M.; Shah, S. I. Administr
- Page 147 and 148:
GomezdeLeon, P.; DiazGarcia,
- Page 149 and 150:
Jackson, L. A.; Starkovich, P.; Dun
- Page 151 and 152:
Kusuhara, K.; Ohga, S.; Hoshina, T.
- Page 153 and 154:
Madjid, M. Acute Infections, Vaccin
- Page 155 and 156:
Naghipour, M.; Nakagomi, T.; Nakago
- Page 157 and 158:
Pool, R.; Mushi, A.; Armstrong, Sch
- Page 159 and 160:
Savidan, E.; Chevat, C.; Marsh, G.
- Page 161 and 162:
Strauman, T. J.; Coe, C. L.; McCrud
- Page 163 and 164:
Vien, N. C.; Feroldi, E.; Lang, J.
- Page 165 and 166:
Akmatov, M. K.; Mikolajczyk, R. T.;
- Page 167 and 168:
Braillon, A. A New French Paradox:
- Page 169 and 170:
Daley, M. F.; Curtis, C. R.; Pyrzan
- Page 171 and 172:
Flu Campaign Receives Excellence Aw
- Page 173 and 174:
Holvast, A.; van, Assen S.; de, Haa
- Page 175 and 176:
Kisakye, A.; Makumbi, I.; Nansera,
- Page 177 and 178:
Makidon, P. E.; Nigavekar, S. S.; B
- Page 179 and 180:
Niu, M.; Ball, R. Adverse Events Af
- Page 181 and 182:
Primus, L. Improving Influenza Vacc
- Page 183 and 184:
Schwartz, B.; Orenstein, W. A. Prio
- Page 185 and 186:
Tharmaphornpilas, P.; Yoocharean, P
- Page 187 and 188:
Weiskopf, D.; Weinberger, B.; Grube